subject area of
- A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes Academic Article
- A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril Academic Article
- B-Type Natriuretic Peptide: Endogenous Regulator of Myocardial Structure, Biomarker and Therapeutic Target Academic Article
- Bradykinin Blocks Angiotensin II–Induced Hypertrophy in the Presence of Endothelial Cells Academic Article
- Cardiac hypertrophy: A matter of translation Academic Article
- Chronic Administration of the Nitroxyl Donor 1-Nitrosocyclo Hexyl Acetate Limits Left Ventricular Diastolic Dysfunction in a Mouse Model of Diabetes Mellitus In Vivo Academic Article
- Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice Academic Article
- Exploiting cGMP-based therapies for the prevention of left ventricular hypertrophy: NO• and beyond Academic Article
- Inhibition of miR-154 protects against cardiac dysfunction and fibrosis in a mouse model of pressure overload Academic Article
- Intrauterine growth restriction coupled with hyperglycemia: effects on cardiac structure in adult rats Academic Article
- Left ventricular dysfunction and exercise capacity trajectory: Implications for subclinical heart failure staging criteria Academic Article
- Organs/Systems Potentially Involved In One Model Of Programmed Hypertension In Sheep Academic Article
- Retinal Arteriolar Narrowing and Left Ventricular Hypertrophy in African Americans. The Atherosclerosis Risk in Communities (ARIC) Study Academic Article
- Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes Academic Article
- The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload Academic Article